Equal Access, Equal Outcomes? Unpacking HIV Treatment Success in Ethiopia
"A new study reveals that primary healthcare centers can deliver antiretroviral therapy just as effectively as hospitals, challenging long-held beliefs."
For years, hospitals have been seen as the gold standard for HIV treatment, particularly in resource-limited settings. The perception has been that their advanced facilities and specialist doctors lead to better outcomes for patients on antiretroviral therapy (ART). But what if that wasn't the whole story?
A groundbreaking study conducted in the Oromia region of Ethiopia is challenging these long-held assumptions. Researchers compared the survival rates and treatment outcomes of adult patients starting ART at primary healthcare centers versus those at hospitals. The findings could reshape how HIV care is delivered, not only in Ethiopia but in similar countries worldwide.
This article dives into the details of this retrospective cohort study, exploring its methodology, key findings, and the implications for the future of HIV treatment accessibility and effectiveness. Get ready to rethink where quality HIV care can be delivered.
Global HIV Treatment Access
At the end of December 2024, 31.6 million people were accessing antiretroviral therapy (ART), up from 7.7 million in 2010, but below the 34 million target for 2025. UNAIDS estimated that 77% of people living with HIV were accessing treatment in 2024. The World Health Organization’s HIV data resource covers global and regional estimates, ART access, testing and care cascades, and progress toward international targets.
The HIV Care Continuum
HIV treatment success depends on access to care and adherence to ART; effective therapy has reduced HIV-related illness and death. The care continuum includes linkage to a provider after diagnosis, regular engagement and retention in care, and adherence to treatment. Linkage can be affected by factors such as insufficient socioeconomic resources, and efforts should be delivered with compassion and persistence. WHO’s January 2026 recommendations provide updated guidance on ART, vertical transmission, and tuberculosis prevention for people living with HIV.
Primary Care vs. Hospitals: Leveling the Playing Field in HIV Treatment
The Ethiopian study, a retrospective cohort analysis, examined data from 1,895 adult patients newly starting ART between October 2010 and January 2014. The patients were treated in either primary health care centers or hospitals within the Oromia region. Researchers meticulously tracked their progress, focusing on key outcomes like survival rates (time to death) and instances of patients being lost to follow-up (LTFU).
- Comparable Survival: The median survival probability was statistically similar between the two groups, meaning patients at primary care centers fared just as well as those in hospitals (P-value = 0.11).
- No Increased Risk: Receiving treatment at a primary health care center did not increase the risk of adverse outcomes (death or LTFU).
- Key Predictors: Regardless of the treatment facility, factors like advanced HIV disease stage at the start of treatment, poor functional status (e.g., being bedridden), and low adherence to ART drugs were the strongest predictors of negative outcomes.
Retention Strategies for Men
A systematic review examined strategies to retain heterosexual men in HIV care in sub-Saharan Africa, including Community ART Groups (CAGs) in Mozambique and six-monthly clinical consultations in Malawi. In the Mozambique cohort reported by Decroo (2017), retention at 12 and 24 months was 88.2% and 80.8% among men, compared with 92.4% and 88.9% among women. The review also reported an attrition rate of 37.9 per 1,000 person-years among men in the Malawi study, compared with 30.5 per 1,000 person-years among women.
Limits of Facility-Based Evidence
A retrospective cohort study in Oromia, Ethiopia, compared survival among adults starting ART at primary health care centers versus hospitals. It used secondary medical-record data collected between October 2010 and January 2014. The authors noted that the facility-based design made it impossible to ascertain registered outcomes independently, so the study relied on outcome ascertainments by case managers at the health facilities.
Implications and the Path Forward
The Ethiopian study carries significant implications for HIV treatment strategies, particularly in resource-limited settings. Decentralizing ART services to primary healthcare centers can ease the burden on overcrowded hospitals, bringing treatment closer to patients and potentially improving access, especially in rural areas.
Promise and Equity of New HIV Treatments
Long-acting ART, including cabotegravir–rilpivirine administered every two months, has shown high efficacy, safety, and preference across diverse populations and age groups, according to the cited commentary. The article frames these injectable formulations as a significant development in HIV management, while noting that advances in treatment and prevention are not reaching everyone equitably. Together, these points highlight both the potential of new treatment options and the importance of ensuring access across populations.
However, it's crucial to acknowledge that simply shifting services isn't enough. The study also underscores the importance of:
<ul><li><b>Early Diagnosis and Treatment:</b> Getting patients into care and on ART as early as possible remains paramount.</li><li><b>Adherence Support:</b> Robust support systems are needed to ensure patients adhere to their medication regimens.</li><li><b>Addressing Underlying Factors:</b> Socioeconomic factors and other health conditions that can impact treatment outcomes need to be addressed holistically.</li></ul><br>By focusing on these key areas, countries can leverage the potential of primary healthcare centers to expand access to effective HIV treatment, ultimately improving the health and well-being of their populations.